Headlines
-
Peak bodies congratulate Albanese
Monday | May 5 2025THE Pharmacy Guild of Australia and Advanced Pharmacy Australia (AdPha) have congratulated Prime Minister Anthony Albanese and Labor on their re-election.
-
CW bank transfer payments incentivised
Monday | May 5 2025CHEMIST Warehouse has announced a "win-win" opportunity for customers and businesses, with a new way to pay by direct bank transfer, securely and in real-time, instead of using a credit or debit card.
-
Pharmacy-GP after hours partnership
Monday | May 5 2025NATIONAL Pharmacies has joined forces with a telehealth service provider, offering Australians 24/7 access to specialist GPs.
-
Coalition vape policy risks youth uptake: PHAA
Friday | May 2 2025THE Public Health Association of Australia (PHAA) has expressed dismay over the Coalition's plan to raise $3.6 billion in revenue over the next four years from vape taxation.
-
Saving lives when it counts
Friday | May 2 2025STAFF at Chemist Discount Centre (CDC) Fawkner in Melbourne had a salient reminder of why pharmacists' work matters when a car crashed into the building a few days ago.
-
All-in-one meningococcal vax
Friday | May 2 2025A MENINGOCOCCAL vaccine covering all five common strains of the deadly disease could soon be available in Australia.
-
Advocating for ADHD
Friday | May 2 2025ADHD Support Pharmacist founder Susan Nguyen (pictured) is passionate about offering compassionate care for individuals living with the disorder and shared her insights in a recent episode of Raven Recruitment's Your Pharmacy Career podcast.
-
Joint call for funding GP-based pharmacists
Thursday | May 1 2025THE Pharmaceutical Society of Australia (PSA) and Royal Australian College of GPs (RACGP) and have joined forces to call on major parties to fund general practice-based pharmacists to work with specialist GPs to support high-quality prescribing and quality use of medicines.
-
First new PBS listing for ALS drug in 20 yrs
Thursday | May 1 2025RADICAVA IV infusion (edaravone, Teva Pharma) is now listed on the Pharmaceutical Benefits Scheme (PBS) for eligible adults with amyotrophic lateral sclerosis (ALS), representing the first new PBS-listed molecule for the treatment of ALS in over 20 years.
-
New Bioderma brand identity aims to highlight skin health
Thursday | May 1 2025A NEW visual identity designed to reflect Bioderma's 45-year legacy of dermatological innovation has been launched by the French skincare brand.
